Moderna’s Coronavirus Vaccine Candidate Appears To Be 94.5% Effective In Interim Analysis

USA Today (11/16, Weintraub) reports Moderna’s SARS-CoV-2 vaccine candidate “appears to be 94.5% effective against the” virus. The vaccine was “developed in collaboration with the U.S. government” and, like Pfizer’s coronavirus vaccine candidate, relies o...